---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-007317"
form_type: "8-K/A"
ticker: "IMMX"
cik: "0001873835"
company_name: "Immix Biopharma, Inc."
filed_at: "2023-03-13T23:59:59+00:00"
generated_at: "2026-06-18T04:56:12.698170+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Immix Biopharma amends 8-K to clarify no deposits at Silvergate or Silicon Valley Bank

## Summary
- Filing corrects original 8-K's item number from 1.01 to 7.01 for Regulation FD disclosure.
- Company confirms neither Immix nor its subsidiaries hold cash deposits or securities at Silvergate Bank or Silicon Valley Bank.
- Disclosure addresses investor concerns during the March 2023 regional banking crisis.

## SEC filing metadata
- accession: 0001493152-23-007317
- form_type: 8-K/A
- ticker: IMMX
- cik: 0001873835
- company_name: Immix Biopharma, Inc.
- filed_at: 2023-03-13T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 1.01, 7.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1873835/000149315223007317/0001493152-23-007317-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1873835/000149315223007317/form8-ka.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-007317
- JSON: https://secwatch.observer/filing/0001493152-23-007317.json
- Plain text: https://secwatch.observer/filing/0001493152-23-007317.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.